.png){kind=icon}
.png){kind=icon}
Return
Advances in CT and MRI for Yttrium-90 Radioembolization of Hepatocellular Carcinoma
.png){kind=icon}
OA
AI
H
K
R
DOI：10.1016/j.acra.2026.06.015.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Transarterial radioembolization (TARE) is increasingly used for patients with hepatocellular carcinoma (HCC) across Barcelona Clinic Liver Cancer stages. It provides local disease control and downstaging or bridging to definitive therapy in selected cases. Imaging plays a central role in patient selection, dosimetry planning, and post-treatment assessment. This review aims to summarize current advances on Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) biomarkers for optimizing TARE clinical management and prognostic evaluation.
Keywords:
Hepatocellular carcinoma
Radioembolization
Computed tomography
Magnetic resonance imaging
Radiomics
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.9
Papers:
8.6K
Citations:
1.0W
Organization
Cited Papers